Tactile Systems (TCMD) Technology announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available throughout the United States for the treatment of both upper and lower extremity lymphedema. Nimbl’s expanded availability to include lower extremity conditions follows its commercial introduction in October 2024, initially focused on treating patients suffering from upper extremity lymphedema.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio